All Stories

  1. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
  2. Vitamin D levels and cancer incidence in 217,244 individuals from primary health care in Denmark
  3. Effect of chemotherapy and aromatase inhibitors in the adjuvant treatment of breast cancer on glucose and insulin metabolism-A systematic review
  4. Chronic Non-bacterial Osteomyelitis: A Review
  5. The association of celiac disease and allergic disease in a general adult population
  6. FRAX Calculated without BMD Resulting in a Higher Fracture Risk Than That Calculated with BMD
  7. Clinical improvement in a patient with monostotic melorheostosis after treatment with denosumab: a case report
  8. Identification and Functional Characterization of a Novel Mutation in the Human Calcium-Sensing Receptor That Co-Segregates With Autosomal-Dominant Hypocalcemia
  9. Modulation of the sympathetic nervous system in youngsters by vitamin-D supplementation
  10. The role of the P2X7 receptor on bone loss in a mouse model of inflammation-mediated osteoporosis
  11. P2Y12 Receptor Antagonist, Clopidogrel, Does Not Contribute to Risk of Osteoporotic Fractures in Stroke Patients
  12. Evidence for the prevention of bone loss in elderly and old early non-metastatic breast cancer patients treated with aromatase inhibitors
  13. Erratum to: determinants of vitamin D status in young adults: influence of lifestyle, sociodemographic and anthropometric factors
  14. P2X7Rs are involved in cell death, growth and cellular signaling in primary human osteoblasts
  15. Letter to the Editor Response: The J-shaped 25-hydroxyvitamin D concentration/CVD-mortality relation is an artifact caused by lack of correction due to age, by Steen Ahrenkiel
  16. Determinants of vitamin D status in young adults: influence of lifestyle, sociodemographic and anthropometric factors
  17. Physical exercise associated with improved BMD independently of sex and vitamin D levels in young adults
  18. Real-Life and RCT Participants: Alendronate Users Versus FITs’ Trial Eligibility Criterion
  19. Vertebral fracture assessment by DXA is inferior to X-ray in clinical severe osteoporosis
  20. Fine-tuned ATP signals are acute mediators in osteocyte mechanotransduction
  21. Perceived age is associated with bone status in women aged 25–93 years
  22. Is allopurinol use associated with an excess risk of osteoporotic fracture? A National Prescription Registry study
  23. The Influence of Clinical Experience and Photographic Presentation on Age Assessment of Women
  24. Serum 25-hydroxyvitamin D and self-reported mental health status in adult Danes
  25. A Reverse J-Shaped Association Between Serum 25-Hydroxyvitamin D and Cardiovascular Disease Mortality: The CopD Study
  26. Response to the letter by Grant
  27. Association between leukocyte telomere length and bone mineral density in women 25–93years of age
  28. Screening for celiac disease in Danish adults
  29. The PRIMARA study to review cinacalcet use in patients with primary hyperparathyroidism
  30. Muscle strength, power and cardiorespiratory fitness are associated with bone mineral density in men aged 31–60 years
  31. A review of lifestyle, smoking and other modifiable risk factors for osteoporotic fractures
  32. Epidemiology of forearm fractures in adults in Denmark: national age- and gender-specific incidence rates, ratio of forearm to hip fractures, and extent of surgical fracture repair in inpatients and outpatients
  33. Genetic variants in theP2RX7gene are associated with risk of multiple myeloma
  34. Non-infectious osteomyelitis of the mandible in a young woman: a case report
  35. Status of drug development for the prevention and treatment of osteoporosis
  36. The P2X7 Receptor: A Key Player in Immune-Mediated Bone Loss?
  37. UTP-induced ATP release is a fine-tuned signalling pathway in osteocytes
  38. The effect of PTH(1-34) on fracture healing during different loading conditions
  39. A Standardized Vascular Disease Health Check in Europe: A Cost-Effectiveness Analysis
  40. Purinergic Signaling in Bone
  41. Low levels of vitamin D are associated with increased mortality in patients attending a university hospital in Denmark
  42. Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status
  43. Clopidogrel (Plavix), a P2Y12receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo
  44. Gastrointestinal Events with Clopidogrel: A Nationwide Population-Based Cohort Study
  45. Short-term teriparatide treatment does not affect NT-proBNP, a marker of cardiac disease
  46. Use of the oral platelet inhibitors dipyridamole and acetylsalicylic acid is associated with increased risk of fracture
  47. A Reverse J-Shaped Association of All-Cause Mortality with Serum 25-Hydroxyvitamin D in General Practice: The CopD Study
  48. Association of P2X7 receptor polymorphisms with bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients
  49. Association of P2Y2 receptor SNPs with bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients
  50. Secondary hyperparathyroidism and mortality in hip fracture patients compared to a control group from general practice
  51. Elevated liver enzymes, anaemia and osteopaenia in a young woman
  52. Paget's disease of the bone after treatment with Denosumab: A case report
  53. Clopidogrel and the risk of osteoporotic fractures: a nationwide cohort study
  54. Determinants of vitamin D status in a general population of Danish adults
  55. Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures
  56. Effects of Increasing Age, Dosage, and Duration of PTH Treatment on BMD Increase—A Meta-analysis
  57. Association between P2X7 Receptor Polymorphisms and Bone Status in Mice
  58. Genetic Background Strongly Influences the Bone Phenotype of P2X7 Receptor Knockout Mice
  59. Clinical and biochemical outcomes of cinacalcet treatment of familial hypocalciuric hypercalcemia: a case series
  60. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans
  61. Effects of Anti-osteoporosis Medications on Fracture Healing
  62. Role of purinergic receptor polymorphisms in human bone
  63. The Evidence for Efficacy of Osteoporosis Treatment in Men with Primary Osteoporosis: A Systematic Review and Meta-Analysis of Antiresorptive and Anabolic Treatment in Men
  64. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution
  65. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
  66. Effect of a program of multifactorial fall prevention on health-related quality of life, functional ability, fear of falling and psychological well-being. A randomized controlled trial
  67. Parathyroid Hormone and Bone Healing
  68. Amylin(1–8) is Devoid of Anabolic Activity in Bone
  69. Glucocorticoid Induced Osteopenia in Cancellous Bone of Sheep
  70. Baseline and Follow-Up Characteristics of Participants and Nonparticipants in a Randomized Clinical Trial of Multifactorial Fall Prevention in Denmark
  71. An Outpatient Multifactorial Falls Prevention Intervention Does Not Reduce Falls in High-Risk Elderly Danes
  72. Protein-containing nutrient supplementation following strength training enhances the effect on muscle mass, strength, and bone formation in postmenopausal women
  73. Osteoporosis in chronic obstructive pulmonary disease patients
  74. Primary and Secondary Prophylaxis to the Use of Inhaled Glucocorticoid in Primary Health Care
  75. Mechanical Muscle Function, Morphology, and Fiber Type in Lifelong Trained Elderly
  76. Effects of treatment with fluoride on bone mineral density and fracture risk - a meta-analysis
  77. Tendon collagen synthesis at rest and after exercise in women
  78. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease—A cross sectional study
  79. Management of risk of glucocorticoid-induced osteoporosis due to systemic administration in general practice in Denmark
  80. Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk – a meta-analysis
  81. MTHFR c.677C>T polymorphism as an independent predictor of peak bone mass in Danish men—results from the Odense Androgen Study
  82. No effect of menstrual cycle on myofibrillar and connective tissue protein synthesis in contracting skeletal muscle
  83. Calcium-Sensing Receptor Induces Proliferation through p38 Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase But Not Extracellularly Regulated Kinase in a Model of Humoral Hypercalcemia of Malignancy
  84. Editorial
  85. Calcium-Sensing Receptor Induces Messenger Ribonucleic Acid of Human Securin, Pituitary Tumor Transforming Gene, in Rat Testicular Cancer
  86. Calcium-sensing receptor stimulates PTHrP release by pathways dependent on PKC, p38 MAPK, JNK, and ERK1/2 in H-500 cells
  87. The calcium-sensing receptor in human disease
  88. Rapid suppression of S-PTH by oral calcitriol and calcium in healthy premenopausal women
  89. Serum levels of parathyroid hormone and markers of bone metabolism in patients with rheumatoid arthritis. Relationship to disease activity and glucocorticoid treatment
  90. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism associated with mutations in the human Ca2+-sensing receptor gene in three Danish families
  91. The Vitamin D Receptor (VDR) Start Codon Polymorphism in Primary Hyperparathyroidism and Parathyroid VDR Messenger Ribonucleic Acid Levels1
  92. Evidence for a role of intracellular stored parathyroid hormone in producing hysteresis of the PTH–calcium relationship in normal humans
  93. Effect of nasal salmon calcitonin on posttraumatic osteopenia following ankle fracture: A randomized double-blind placebo-controlled study in 24 patients
  94. A mathematical/physiological model of parathyroid hormone secretion in response to blood-ionized calcium loweringin vivo
  95. Parathyroid hormone secretion in chronic renal failure
  96. Inter-relations between the calcium set-points of Parfitt and Brown in primary hyperparathyroidism: a sequential citrate and calcium clamp study
  97. Cica-clamp technique: a method for quantifying parathyroid hormone secretion: a sequential citrate and calcium clamp study
  98. Changing incidence and residual lifetime risk of common osteoporosis-related fractures
  99. Radial and humeral fractures as predictors of subsequent hip, radial or humeral fractures in women, and their seasonal variation
  100. Normal pattern of parathyroid response to blood calcium lowering in primary hyperparathyroidism: a citrate clamp study
  101. Induced hypocalcaemia and intact PTH responsiveness in patients with primary hyperparathyroidism, primary hypoparathyroidism and normal man
  102. Calcium clamp technique: Suppression of serum intact PTH by induced hypercalcaemia in normal man and primary hyperparathyroidism
  103. Induced hypocalcaemia controlled by a citrate clamp technique, and the intact parathyroid hormone response obtained